Zoono® Group is an ASX listed biotech company specialising in Developing, manufacturing and distributing a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions.
The 'Zoono® molecule' is Zoono’s® unique germ popping technology that is proven to stay active for up to 24 hours on skin and up to 30 days on surfaces.
Zoono® has been operating since 2008 based in Auckland (New Zealand), with additional offices in New Jersey (United States of America) and Bury St Edmunds (United Kingdom), Shanghai, China.
The exclusive low toxicity ZOONO® formulation is water-based and meets food contact and food packaging safety legislation from national government agencies. It kills many bacteria and viruses on surfaces long after applied and continuously outperforms competing antimicrobial solutions.
With a shelf life of 4 years efficacy within a wide temperature range, it is now available for use around people, pets and plants in homes and business.
Leading organisations around the world use Zoono® to help prevent the spread of disruptive pathogens.
Zoono’s mission is to:
“Improve health and well-being through innovative, safe, non-toxic and durable germ protection”